Andrea Forschner
University Children's Hospital Tübingen(DE)University of Tübingen(DE)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy(2016)638 cited
- → Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy(2016)556 cited
- → Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study(2019)209 cited
- → Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition(2017)198 cited
- → Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma(2017)184 cited
- → Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases(2012)152 cited